Literature DB >> 32321817

Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.

Christiane S Eberhardt1,2,3, Andreas Wieland1, Tahseen H Nasti1, Alba Grifoni4, Elizabeth Wilson1, D Scott Schmid5, Bali Pulendran6, Alessandro Sette4,7, Edmund K Waller8, Nadine Rouphael9, Rafi Ahmed10.   

Abstract

Childhood immunization with the live-attenuated varicella-zoster virus (VZV) vaccine induces protective immune responses. Routine VZV vaccination started only 2 decades ago, and thus, there are few studies examining the longevity of vaccine-induced immunity. Here, we analyzed the quantity of VZV-specific plasma cells (PCs) and CD4 T cells in the bone marrow (BM) of healthy young adults (n = 15) following childhood VZV immunization. Long-lived BM resident plasma cells constitutively secrete antibodies, and we detected VZV-specific PCs in the BM of all subjects. Anti-VZV plasma antibody titers correlated positively with the number of VZV-specific BM PCs. Furthermore, we quantified the number of interferon gamma (IFN-γ)-producing CD4 T cells specific for VZV glycoprotein E and all other structural and nonstructural VZV proteins in both BM and blood (peripheral blood mononuclear cells [PBMCs]). The frequency of VZV-specific IFN-γ-producing CD4 T cells was significantly higher in PBMCs than BM. Our study shows that VZV-specific PCs and VZV-specific CD4 memory T cells persist up to 20 years after vaccination. These findings indicate that childhood VZV vaccination can elicit long-lived immune memory responses in the bone marrow.IMPORTANCE Childhood varicella-zoster virus (VZV) immunization induces immune memory responses that protect against primary VZV infection, chicken pox. In the United States, routine childhood VZV vaccination was introduced only 2 decades ago. Hence, there is limited information on the longevity of B and CD4 T cell memory, which are both important for protection. Here, we showed in 15 healthy young adults that VZV-specific B and CD4 T cell responses are detectable in bone marrow (BM) and blood up to 20 years after vaccination. Specifically, we measured antibody-secreting plasma cells in the BM and VZV-specific CD4 T cells in BM and blood. These findings suggest that childhood VZV vaccination induces long-lived immunity.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CD4 T cells; adaptive immunity; bone marrow; immune memory; plasma cells; varicella vaccines; varicella-zoster virus

Mesh:

Substances:

Year:  2020        PMID: 32321817      PMCID: PMC7307153          DOI: 10.1128/JVI.02127-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

2.  Humoral immunity due to long-lived plasma cells.

Authors:  M K Slifka; R Antia; J K Whitmire; R Ahmed
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

3.  Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-07-12

4.  Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells.

Authors:  Dietmar Herndler-Brandstetter; Katja Landgraf; Brigitte Jenewein; Alexandar Tzankov; Regina Brunauer; Stefan Brunner; Walther Parson; Frank Kloss; Robert Gassner; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

5.  Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.

Authors:  Sinu Paul; Cecilia S Lindestam Arlehamn; Thomas J Scriba; Myles B C Dillon; Carla Oseroff; Denise Hinz; Denise M McKinney; Sebastian Carrasco Pro; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol Methods       Date:  2015-04-07       Impact factor: 2.303

6.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

7.  Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.

Authors:  Sheila Weinmann; Colleen Chun; D Scott Schmid; Michelle Roberts; Meredith Vandermeer; Karen Riedlinger; Stephanie R Bialek; Mona Marin
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

8.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

Review 9.  Immune senescence and vaccines to prevent herpes zoster in older persons.

Authors:  Myron J Levin
Journal:  Curr Opin Immunol       Date:  2012-08-02       Impact factor: 7.486

10.  Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory.

Authors:  Anna Okhrimenko; Joachim R Grün; Kerstin Westendorf; Zhuo Fang; Simon Reinke; Philipp von Roth; Georgi Wassilew; Anja A Kühl; Robert Kudernatsch; Sonya Demski; Carmen Scheibenbogen; Koji Tokoyoda; Mairi A McGrath; Martin J Raftery; Günther Schönrich; Alessandro Serra; Hyun-Dong Chang; Andreas Radbruch; Jun Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

View more
  3 in total

1.  Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination.

Authors:  Alessandro Sette; Alba Grifoni; Hannah Voic; Rory D de Vries; John Sidney; Paul Rubiro; Erin Moore; Elizabeth Phillips; Simon Mallal; Brittany Schwan; Daniela Weiskopf
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

2.  Acceptance of varicella vaccination.

Authors:  Andrea Horváth
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

3.  Inadequate Vaccine Responses in Children With Multiple Sclerosis.

Authors:  Jonathan D Santoro; Laura E Saucier; Runi Tanna; Sarah E Wiegand; Dania Pagarkar; Adam F Tempchin; Mellad Khoshnood; Nusrat Ahsan; Keith Van Haren
Journal:  Front Pediatr       Date:  2021-12-01       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.